Armistice Capital’s SteadyMed Ltd STDY Stock Holding History

Armistice Capital’s Portfolio STDY Stock Details STDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-497,044	Closed	-$2.24M	–	97
2018 Q2	$2.24M	Buy	+497,044	New	+$2.03M	0.15%	65

Other funds holding STDY

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Appleton Partners Boston, Massachusetts $1.43B AUM 22.6% 1-Year Est. Return

HCMT

Highland Capital Management (Tennessee) Memphis, Tennessee $1.89B AUM 33.93% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Armistice Capital's STDY Position: Q3 2018 in Review

Armistice Capital sold out of SteadyMed Ltd (STDY) in Q3 2018, closing a stake of 497,044 shares — an estimated $2.24M sold.

Armistice Capital first reported a position in STDY in Q2 2018 and held it in 1 quarter. The position peaked at $2.24M in Q2 2018. 5 funds tracked by Wall St. Rank hold STDY as of Q3 2018.

Armistice Capital reported no remaining SteadyMed Ltd position as of Q3 2018 after selling out during the quarter.
Armistice Capital sold 497,044 SteadyMed Ltd shares in Q3 2018, an estimated $2.24M.
Armistice Capital first reported a position in SteadyMed Ltd in Q2 2018 and held it in 1 quarter.
Armistice Capital's SteadyMed Ltd position peaked at $2.24M in Q2 2018.
5 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2018.

Based on Armistice Capital's 13F filing for Q3 2018, filed 14 Nov 2018.